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ABSTRACT: 
An empirical study of scientific communication among biotechnology companies 
supports the belief that geographic clustering does produce increased scientific 
exchange among companies.  A comparison of companies within a constrained 
geographic area with those more dispersed shows a significantly higher level of 
scientific communication among the former.  Scientific communication declines 
rapidly with plupical separation. 
 
Critical of the formation of cluster – based scientific communication networks is the 
presence of both universities and large firms from the same industry. 
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INTRODUCTION 
In this age of ubiquitous broadband connectivity, one might expect that the effect of 
separation distance on communication might have disappeared or at least be 
diminished. 
 
If this is true, then one of its effects would be to disarm the arguments for similar 
firms, especially those newly formed and technology-based to cluster geographically.  
Now there are many arguments for the benefits of geographic clustering, not the least 
of which is that a concentration of firms will attract resources, particularly of the 
human kind into an area.  Still, the potential for synergy among like firms is 
considered a strong factor for locating in what often becomes a high rent district.  It is 
widely believed that propinquity will stimulate communication and scientific 
exchange among firms, especially among small firms formed on the basis of a 
common technology.  This is one of the basic premises supporting the argument for 
the geographic clustering of newly-formed high technology firms (Powell et. al, 
1996).  Extensive research in recent years has demonstrated economic benefits for 
firms sharing a common technology within the same geographic cluster.  Researchers 
identify different benefits to be derived from clustering.  It will be easier to attract 
specialized staff, because the qualified pool of applicants is much larger.  It is also 
easier to find venture capital, suppliers, and support services within a cluster 
(Saxenian, 2003).  Claims have also been made for the synergistic benefits of firms 
sharing scientific knowledge, especially if there are university laboratories near the 
cluster (Saxenian, 2003). 
 
Several studies have inferred inter-firm communication from the evidence of co-
publishing and co-patenting across firms, (Schilling & Phelps, 2005; Porter, Powell & 
Porter, Whittington & Powell, 2007).  This is certainly a valid and effective way of 
detecting inter-firm communication, however a good amount of scientific exchange 
may occur that does not result in such products and does not therefore appear in such 
publicly accessible records.  This less formal scientific exchange across firms while 
resulting in a patent or paper may still produce value for the communicating 
companies. 
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Of course, the arguments for communication being related to proximity, in other 
contexts have been around for a long time.  Allen (Allen and Henn, 2006), for 
example, has shown the probability of regular technical communication among 
engineers to decline as the inverse square of the distance between their work stations. 
 
Of course, this decline was predicated on the need for face to face contact.  So it does 
nothing to dispel the belief that modern media have diminished that need.  This is in 
spite of the fact, that Hauptman and Allen (1987) showed face-to-face to be the 
preferred medium for complex or abstract messages, such as those typifying scientific 
communication.  We are now in a new millennium and their work is more than twenty 
years old.  Technology has advanced since their time and, probably more importantly, 
a new generation of scientists, more at home with modern media, has arrived on the 
scene.  So today we may find less need for companies to cluster geographically.  
Scientists can potentially communicate effectively across firms through media other 
than face to face. 
 
Many contemporary observers are now telling us that the day has arrived when we 
can forget about distance in its effect on communication.  In fact, an eminent 
economist, Frances Cairncross has declared (in the title of her book) that distance is 
dead, "…new communications technologies are rapidly obliterating distance as a 
relevant factor in how we conduct our business and personal lives…" (Cairncross, 
2001). 
 
Does Distance Really No Longer Matter? 
If Cairncross and others are really correct, there is no longer a rationale for the 
geographic clustering of new venture firms.  Therefore one of our purposes in this 
research is to measure the effects of geographic proximity on communication among 
firms.  Allen’s work is both dated and based upon the study of communication among 
engineers and scientific all working within single organizations.  A question remains 
whether Allen’s observations carry through to communication among scientists in 
separate firms and living in a new millennium.  The availability of an already existing 
biotechnology cluster in parts of Cambridge and Boston, Massachusetts provides a 
convenient opportunity to test this question. 
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This biotechnology cluster developed adjacent to MIT in Cambridge, Massachusetts.  
This so-called ‘cluster’ of mostly newly-formed biotechnology firms has come about 
over the past 20 to 30 years and continues to grow.  Depending upon one’s definition 
of what a biotech firm is, the number can range from 80 to over 200 firms.  The 
Massachusetts Biotechnology Council, an industry trade association lists over 500 
companies as members.  We will be a bit more conservative and restrict our selection 
on the basis of location and the nature of the firm’s principal activity.  We thus end up 
with fewer than 100 companies.  Nevertheless, this is a sufficient size for a 
meaningful study. 
 
Our Basic Hypothesis: 
When firms locate near one another a number of factors potentially influencing 
communication come into play.  First of all, formal intentional communication is 
easier.  Walking across the street is certainly easier than traveling a greater distance 
by car or plane.  Informal communication is also more likely due to chance 
encounters.  Finally, and influencing chance encounters, is the use of common 
facilities and locations such as restaurants, coffee shops, fitness centers, etc. 
 
As far as we know, measurement similar to what Allen and his colleagues did for 
person-to-person communication has never been made for inter-firm communication.  
However, we see no reason that such communication would not be negatively 
affected by physical distance.  We will in several ways test that hypothesis in this 
paper: 
 
First we will ask whether those firms located within the geographic bounds of the 
cluster communicate more themselves and show greater centrality in the 
communication network among organizations than do firms in the general region but 
outside the geographically defined boundaries.  Then we will test whether the total 
amount of scientific communication reported by any organization with other 
organizations in the study will decline with the mean geographic distance between 
that organization and those other organizations. 
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Research Method 
The Geographic Cluster 
The geographic extent of the cluster is defined through the use of postal zones (Zip 
Codes).  We choose these on the basis of the concentration of firms shown in the MIT 
Sloan School of Management Entrepreneurship Center’s map of the location of firms 
(Figure 1). 
 
Some of these postal zones cover part of Cambridge and others were in the City of 
Boston.  They were generally in the vicinity of Harvard University, MIT, Boston 
University or Harvard Medical School.  Organizations located outside of these regions 
will be employed as a control group. 
 
Figure 1  A Street Map of Cambridge and Boston, Massachusetts Showing the Locations of 
Biotech Companies.  (Courtesy of MIT Sloan School of Management Entrepreneurship Center). 
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Biotechnology Companies 
We were able to create an accurate listing of firms with the kind assistance of the 
Massachusetts Biotechnology Council and the MIT Entrepreneurship Center.  We 
compiled a database listing of Boston’s’ biotechnology firms, pharmaceutical firms, 
hospitals and universities.  Around 90 firms, hospitals and universities are located 
within the geographic cluster (Boston and Cambridge) while another 100 firms are 
located in a variety of suburbs.  In order to focus our attention onto those firms 
working on human therapeutic applications of biologically-derived pharmaceuticals, 
we eliminated all companies that were in the agricultural, veterinary, and 
environmental products and services fields from the initial listings.  We also 
eliminated those with a primary focus on diagnostics as opposed to therapeutics.  This 
left us with a final sample of around 70 firms.  Of these, we received data from 401 
companies.  In each of the cooperating companies, we select a random listing of 
approximately ten percent2 of their bench-level scientists.  The chosen scientists must 
have at least a PhD or MD level of education and be actively engaged in research. 
 
Big Pharma  
A number of ‘Big Pharma’ or large broadly-based traditional pharmaceutical firms 
have recently located research operations in the Cambridge/Boston area.  The goal of 
these larger firms is undoubtedly to tap into the scientific communication network that 
may exist among the smaller, newly-formed firms.  Their longer-term goal is probably 
to acquire new technology and products through licensing from or acquisition of the 
firms owning the intellectual property.  The large pharmaceutical firms are also 
included in our sample, to determine the degree to which they are successful in 
attaining this goal3. 
                                                 
1 The failure to reach all 70 companies is not due to low response from the companies.  In fact, only one company 
declined to participate.  It was instead due to our inability to reach all 70.  This, in turn, was due to a lack of 
resources and time.  There were only two of us working at that point in the study. 
2 In companies with fewer than 10 scientists, we sample all of those engaged in bench level research.  Cooperation 
is, of course, voluntary and the overall research plan has been reviewed and approved by the MIT Committee on 
the Use of Human Experimental Subjects. 
3 While the presence of the larger firms in many ways is a benefit to the startups, since they bring resources in the 
form of much needed money for licensing or even outright acquisition, this is not universally viewed in a positive 
 8 
 
 
A Control Group 
Many of the firms, from which we collected data, are located outside of our selected 
postal zones.  These more distant firms provide a convenient control group for 
comparison with the experimental group located within the selected postal zones. 
 
Universities 
There are five large research-based universities located within the selected postal 
codes.  These are included in the study in a less direct way.  Instead of asking 
scientists in the universities to report their communications, we rely on the reports of 
those in firms, who communicate with university scientists.  Our reasoning for this is 
nothing more complex than ease of data collection.  The initial phase of collecting 
data only on communication will be followed by a web survey in which we will seek 
further information on the exact university laboratories with which communication 
took place, the origins of the contact, etc.  In looking at the universities, we hope to 
find the degree to which firms originating from these universities retain their 
connection with their ‘mother’ organizations as well as the degree to which firms born 
elsewhere are able to develop relations with universities within the region. 
Measuring the Structure of Communication Networks; A Web-
based Research Method 
As noted before, many current studies rely upon patent and publication databases and 
therefore are unable to detect communication that while significant may not result in 
such products.  To capture this type of communication, we adapted a tool that we had 
previously used in the study of communication among individual scientists within 
organizations.  In addition to being sensitive enough to capture much of this 
additional communication the web-based tool is also easy to use and is able to sense 
the dynamic aspect of the communication network as it evolves. 
 
                                                                                                                                            
light.  One entrepreneur described the relationship of firms such as his with ‘Big Pharma’ as “…a bunch of 
monkeys playing with gorillas”.  He was very concerned with protecting his intellectual property or at least getting 
what he considered a fair price for it. 
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An email message with a link to a web page is sent once each week to each scientist.  
The web page contains a list of the names of the biotech/ pharmaceutical 
organizations (including universities and hospitals) in the area.  An example is shown 
in Figure 2.  A scientist has merely to open the page and by mouse-click indicate 
which organizations (if any) that scientist had contact with on that particular day.  
This simple exercise, which can be completed in one minute or less, is then repeated 
on randomly chosen days, approximately once per week for a period of six months.  
The results collected with this tool provide a measure of the pattern of communication 
among the organizations and this can be related to measures of success. 
 
The software tool we use to analyze the network is called Condor4.  Condor reveals 
the evolution of interaction patterns in social networks.  It provides an environment 
for the visual identification and analysis of the dynamics of communication in social 
spaces5. (Gloor, 2006). 
 
                                                 
4 Formerly TeCFlow. 
5 The framework is based on a multi-year research project on Collaborative Knowledge Networks by a global 
group of universities under the leadership of the MIT Center for Collective Intelligence and the Center for Digital 
Strategies at the Dartmouth Tuck School of Management (see http://www.ickn.org/ickndemo/). 
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Figure 2  An Example of the Structure of the Web Page Used in Collecting Communication Data. 
 
 
Data Analysis 
 
The first step in our data analysis is to plot the network of communication among 
scientists in the organizations in our sample (Figure 3).  In this plot, each organization 
is represented as a network node.  Pairs of nodes are connected if there is any 
communication reported between them.  The length of each connection is inversely 
proportional to the amount of communication reported over the six month period of 
the study6. 
 
The network of Figure 3 exhibits an interesting characteristic.  There is a set of 
organizations in the center, that have a higher than average level of communication, 
                                                 
6 Since it was impossible to visit and recruit all 40 collaborating firms on the same day, we used a sliding window.  
Data collection began on a slightly different day for each firm and continued for six months.  So the six month 
period of data collection is slightly different (but overlapping) for each firm.  This could have had serious for the 
study had something critical had affected the industry during the study.  Fortunately for the investigators, no such 
untoward event occurred. 
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among themselves.  Thus, there appears to be a sub-cluster, or perhaps a super cluster 
of high communicating organizations concentrated in the center of the overall 
network.  It will be interesting to examine the membership of this super cluster 
(Figure 4). 
 
 
Figure 3  A View of the Interorganizational Scientific Communication Network as Reported by 
Scientists in a Sample of Biotech Firms and Organizations in the Area of Eastern Massachusetts, 
USA. 
 
However, before we get into the task of identifying membership7, let us look at one of 
our basic hypotheses.  If the geographic propinquity of firms in a cluster enables more 
intense communication, this should be observable in our network.  As a first step in 
testing this, we divided the entire set of organizations into two groupings viz., the 
previously defined experimental and control groups. 
 
Using the degree of centrality of each node within the network (reference) as a metric 
for communication, we can compare the two groups (Figure 4).  This reveals a 
significant difference in their centrality or embeddedness in the network.  Those 
organizations within the geographically defined cluster region have nearly twice as 
many connections with other organizations (Figure 4).  Since centrality indicates the 
number of other firms with which a given firm may be in contact but not the amount 
of contact, we also compare the experimental and control firms on the basis of the 
                                                 
7 No organizations, aside from universities will be specifically identified.  Understanding what can be the result 
when people can identify high and low communicators, for example, we have had a standard policy, for many 
years of concealing identities.  We will therefore identify only classes of organization. 
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amount of communication reported (Figure 5).  Here we find that scientists in firms 
that are within the geographic bounds of the cluster reported that along with 
distributing communication across a larger number of firms, they also simply 
communicated more.  Thus we have the first elements of support for our basic 
hypothesis.  Physical propinquity within a cluster may or may not be the cause of 
greater communication but it certainly correlates very strongly with the amount of 
inter-organizational scientific communication and assuredly makes it easier to attain 
greater levels of communication. 
 
 
Figure 4  Mean Centrality of Organizations 
in the Experimental and Control Groups. 
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Figure 5.  Mean Level of Communication 
of Organizations in the Experimental and Control 
Groups. 
 
With some support for the communication benefits 
of clustering, let us learn a little more about the 
nature and makeup of the Cambridge/Boston 
cluster.  We will do this graphically first by 
arbitrarily defining an area of concentration within 
the network of Figure 3.  This will tell us the types of organization to be found within 
the region of intensive communication seen in the center of Figure 3.  We will then 
turn to physical location and see what types of organization are actually located 
physically within the formally defined bounds of the cluster. 
 
Figure 6  A View of the Center of the Network 
 
Categories of 
Organization 
Now to complicate things 
but make the analysis more 
interesting as well, not all of 
the organizations in the 
network of Figure 3 are 
newly-formed Biotech 
firms.  As previously 
mentioned, there are also five universities, six8 large scale broad-based (traditional) 
pharmaceutical firms and five larger, more established biotechnology firms.  So let us 
look at each of these classes of organization separately. 
 
Where are the Universities? 
Four of the five universities can be readily identified within the network region that 
we have arbitrarily labeled a “super cluster” (Figure 6).  The remaining two are in the 
                                                 
8 Two of these have merged since the study.  However, we will continue to treat them as separate in the study. 
 14 
 
network but further from the center.  The two most central universities are Harvard 
(Medical School) and MIT.  These were the two principal sources from which a 
majority of the new biotech firms originated.  It is therefore not at all surprising to 
find their ‘children’ tightly connected to them.  The parent locations are probably the 
chief reason why the newly formed firms located where they did.  In fact, our choice 
of defining the geographic limits of the cluster by postal codes was based upon the 
locations of the ‘parent’ universities.  We chose postal code zones that included the 
addresses of the principal universities.  In addition, although the communication data 
cannot tell us this, interviews indicate that proximity to these universities was also a 
major factor underlying the location decisions of the major pharmaceutical firms. 
 
What about “Big Pharma”? 
As stated above, there are five major pharmaceutical companies that have located in 
or near the experimental region.  One of these has R&D activities at two sites about 
33 Km apart.  So there are really six sites at which these large companies are active in 
R&D.  Certainly, the principal reason for these large firms locating in the Boston area 
is the presence of so many newly-formed Biotech firms in that region.  To put it 
simply, they want to become members of the scientific communication network.  In 
addition to university contact that their location enables, we would speculate that 
since most major pharmaceutical firms are working to develop new biologically based 
drugs, that they see membership in the network as an aid toward that goal.  So how 
successful have they been?  One does not have to look very long at Figure 6 to 
conclude that at least four of these firms have been very successful in at least gaining 
network membership.  They are centrally located in the heart of the super cluster.  
Their scientists are in close communication with scientists in several smaller firms as 
well as in the universities. 
 
 
Figure 7. Center of the Network, 
Highlighting the Universities. 
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Figure 8.  Center of the Network Highlighting the Universities and the 'Big Pharma' Firms. 
 
 
 
 
 
‘Big Bio’ 
We designated a subset of the biotechnology firms as ‘Big Bio’ simply on the basis of 
size and age.  Such firms as Biogen, Amgen, Serono, Genzyme and Millennium are 
no longer new ventures.  They are all large firms and have been in existence for more 
than a few years.  Where are they in the network?  Even a quick look at Figure 9 
indicates that they are at least as central to the network as the larger pharmaceutical 
firms. 
 
 
Figure 7.  Center of the Network Highlighting the Universities, 'Big Pharma' and 'Big Bio'. 
 
 
 
 
 
 
 
Comparisons on the Basis of Type 
of Organization. 
We can see from the network that both ‘Big Pharma’ and ‘Big Bio’ are very well 
connected into the central core.  The universities are as well but that is no surprise 
since they are the parents out of which most of the new ventures originated.  We will 
now look and see in a more quantitative manner, just how embedded they are.  At 
least in the case of the ‘Big Pharma’, this will be a test of how successful they have 
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been in invading the network originally formed among the new venture firms.  That 
they have been successful can be clearly seen in Figure 10. 
 
Perhaps the most interesting aspect, though, is the low value of mean centrality for the 
small biotech firms.  These are the firms who initially formed the network.  Of course 
the universities were there from the beginning too, so it is no surprise to find them 
with a high degree of centrality.  The larger firms were for the most part later arrival 
and they are on average more deeply embedded than the startup firms. 
 
Figure 8.  Mean Network Centrality for 
Four Categories of Organization. 
 
 
 
 
This certainly seems strange, 
but one possible explanation 
might be that these firms are not as old as we might initially assume.  The set might 
be dominated by newly formed companies that haven’t had sufficient time to embed 
themselves in the network.  However, a closer look at the data shows this explanation 
to be invalid.  Instead of the younger small companies having lower network 
centrality, they actually have on average a higher degree of centrality than do the 
older small firms (r = -0.45, p = 0.05).  This significant negative correlation does not 
occur for the larger firms and universities.9 
 
Network centrality tells us how many organizations, on average, organizations of a 
particular type communicate with.  It does not reveal just how much communication 
actually occurs.  Turning to that measure, we find the smaller firms in a much 
stronger position (Figure 11).  Although the differences that appear in Figure 11 are 
                                                 
9 When the data from the universities, Big Pharma and Big Bio firms are combined the correlation between age 
and network centrality is positive, but not statistically significant. 
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not significant statistically, we can say that the smaller firms do not appear to be any 
less active in interorganizational scientific communication than their larger neighbors. 
Once again, however, what appear anomalous results for the smaller biotech firms.  
The older firms in this category report significantly less scientific (r = -0.51, p = 0.02) 
communication outside of the firm than do the larger firms. 
 
What we seem to be seeing here is that the newly formed firms work harder to 
establish scientific exchange with many neighboring organizations (not just with their 
university parent) and as they grow older, they narrow the number of targets for this 
activity and increase the amount of communication with this smaller number of 
organizations. 
 
 
Figure 9.  Interorganizational Scientific Communication 
Reporte by Organizations in Three 
Categories. 
 
 
Mean Distance & 
Communication 
As a further test of the basic 
clustering hypothesis, we 
measured the physical distances separating each pair of firms.10  Then for each firm, 
we computed the mean separation distance of that firm from all of the others.  In 
Figure 12, we see that communication frequency is inversely related to inter-company 
distance.  The inter-company distances are expressed in kilometers and were 
calculated using the coordinates of latitude and longitude for each company11.  Total 
communication was then plotted for each value of mean inter-company distance.  As 
                                                 
10 We did this by obtaining the latitude and longitude of each firm and then computing the straight-line distance.  
Of course, there are several inherent in such a calculation.  First, the geographic position that we work from is that 
of the front door of the facility.  Second, the distance measured does not take into the indirect paths that one would 
have to travel to go between firms. 
11 The circular error probability for each company location is about 800 meters. 
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in our previous research, it is best expressed by a 1/x2 relationship as communication 
quickly decays as distance increases. 
 
Figure102.  Interorganizational Scientific Communication Reported 
as a Function of Mean Separation distance from Other Organizations. 
 
Each point on the graph 
in Figure 12 represents 
one company in our 
sample.  The x-axis 
coordinate is the mean 
distance between that 
company and all of the 
other organizations.  In 
other words, it is how far, 
on average, this 
particular company is from all of the other organizations in our sample.  Because of 
the large concentration of companies in the experimental area, those with low average 
inter-company distances are in or very close to the geographic center of the biotech 
cluster.  The vertical coordinate is the total amount of communication reported by that 
given company with all of the others. 
 
This graph shows that companies in the physical center of the biotech cluster 
communicate more with other companies.  As mean separation distance increases, the 
total communication with other companies decreases as 1/x2. 
 
Since we did not ask scientists to report the medium used for each communication, 
this number could include email and telephone as well as face-to-face.  Why then 
would it decay with distance?  We do not have a definitive answer for that.  However, 
there is evidence from a study by Allen & Hauptman (1987), that the use of different 
communication media is positively correlated.  Regardless, however, of whether the 
communications were face-to-face, the important fact is the decline with distance.  
Those declaring the death of distance are at least in this instance patently wrong.  
Separation distance does matter in the 21st Century, and these data once again support 
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the idea of clustering high tech new ventures or at least biotechnology firms together 
geographically. 
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